Ascendis Pharma A/S American Depositary Shares
Symbol: ASND (NASDAQ)
212.03
▲ (5.48%) 11.021
Company Description:
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
Key Stats
- Today's Open: $212.04
- Today's High: $212.04
- Today's Low: $212.031
- Today's Volume: 20
- Yesterday Close: $201.01
- Yesterday High: $203.605
- Yesterday Low: $199.81
- Yesterday Volume: 240.98K
- Last Min Volume: 20
- Last Min High: $212.04
- Last Min Low: $212.031
- Last Min VWAP: $212.04
Company Profile
- Name: Ascendis Pharma A/S American Depositary Shares
- Website: https://www.ascendispharma.com
- Listed Date: 2015-01-28
- Location: ,
- Market Status: Active
- CIK Number: 0001612042
- SIC Code:
- SIC description:
- Market Cap: $12.15B
- Round Lot: 100
- Outstanding Shares: 60.55M
- Asset Type: ADRC
RECENT FILINGS FOR ASND
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-22 | 6-K | View |
| 2025-10-15 | 6-K | View |
| 2025-10-08 | 6-K | View |
| 2025-09-30 | 6-K | View |
| 2025-09-10 | 6-K | View |
| 2025-09-09 | 144 | View |
| 2025-08-29 | 144 | View |
| 2025-08-27 | 144 | View |
| 2025-08-20 | 144 | View |
| 2025-08-15 | 144 | View |
| 2025-08-14 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | 144 | View |
| 2025-08-13 | 144 | View |
| 2025-08-13 | 6-K | View |
| 2025-08-13 | SCHEDULE 13G | View |
| 2025-08-12 | 144 | View |
| 2025-08-07 | 6-K | View |
| 2025-08-07 | 6-K | View |
Latest News on ASND